8eoc agenda 2019 - downloadable 003€¦ · king faisal specialist hospital & research center,...

جميرا في إبراج االتحاد، أبوظبي، ا�مارات العربية المتحدةJumaeirah Etihad Tower Abu Dhabi, United Arab Emirates

November 7-9, 20197-9 نوفمبر 2019

www.tawameoc.ae

المناقشات و التحديات في عالج ا�ورامConsensus, Controversies & Challenges

in Multidisciplinary Cancer Care

AGENDA

0700-0800 REGISTRATION

Chair persons: Zainab Alshaban / Asif Quadri / Dr. Arif Chehal / Saleem Chaibrasou

0800-0805 Welcome Speaker: Saad Ghazal-Aswad

0805-0825 Eradicating Cervical Cancer Plan in UAE Speaker: Saad Ghazal-Aswad

0825-0845 Controversies in Management of Pelvic Mass Speaker: Thikra Hassan

0845-0905 Molecular Genetics in Endometrial Cancer Speaker: Ismael Badawi

0905-0930 Recent Advances in the Surgical Management of Endometrial Cancer Speaker: Jill H. Tseng

0930-0945 COFFEE BREAK

0945-1005 Optimising Surgical Outcome in Ovarian Cancer Speaker: Jill H. Tseng

1005-1030 Any Role for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer Speaker: Ismael Badawi

1030-1100 Tumour Board Moderator: Saad Ghazal-Aswad - Mohammed Salamat (Radiology)

Gynaecological Oncology

www.tawameoc.ae

Day 1

AM

Thursday 7th November 2019

Consensus, Controversies & Challengesin Multidisciplinary Cancer Care

Jumaeirah Etihad Tower Abu Dhabi, United Arab Emirates

www.tawameoc.ae

Day 1

AM



in Multidisciplinary Cancer Careجميرا في إبراج االتحاد، أبوظبي، ا�مارات العربية المتحدةJumaeirah Etihad Tower Abu Dhabi, United Arab Emirates

Plenary Session # 1

Chair Person: Sultan Al Karam

1100-1130 Topic: “Hyperthermia in various forms and as integrative part for chemotherapy and radiotherapy. What is secured? - A chance or charlatanry Speaker: Hüseyin Sahinbas

1130-1200 Topic: Stereotactic Body Radiation Therapy Speaker: Helmut Hollenhorst

www.tawameoc.ae

Day 1

AM





Chair persons: Mahmoud Hassan / Jihad Yaseen

08:00-08:10 Opening and welcoming Speaker: Mahmoud Hassan

08:10-08:25 When the Family Requests Withholding the Diagnosis: Who Owns the Truth? A prospective study among adult cancer patients in the UAE Speaker: Reshma Pisal

08:25 -08:50 Autologous bone marrow transplant (Nursing Role) Speaker: Kathy Mooney

08:50-09:05 Enhancing Patient Advocacy through Palliative Care Initiatives (End-of-Life Communication) Speaker: Mehad Araki

09:05 – 09:20 Developing an Urgent Symptom Telephone Triage Model – Tawam Experience Speaker: Wafa Hanjouri

09:20 - 09:30 Questions & Answers


9:45 – 10:00 Planning the future: Building a world class comprehensive cancer center, Nursing Leadership Lessons Speaker: Zeina Kassem10:00 -10:25 The use of Pediatric protocol, ALL in Adolescent and young adult (AYA) age-group (15 to 26 years) Speaker: Mikaela Olsen10:25-10:50 Case Study: The management of Lung cancer with oncologic emergencies Speaker: Mohd Saleh10:50-10:55 Questions & Answers10:55-11:00 Closing Remarks Speaker: Jihad Yaseen

Nursing

www.tawameoc.ae

Day 1

AM





Chair persons: Nahed Ahmed Balalaa / Guido Hein Huib Mannaerts Ateq Ali Al Messabi / Mariam Al Marashda

0800-0820 Robot Assisted Radical Prostatectomy: surgical anatomy and how to optimize functional and oncological outcomes Speaker: Aftab Bhatti

0820-0840 Thoracoscopic lung resections Speaker: Edward Black

0840-0900 Breast sparing and breast reconstructive surgery Speaker: Mouza Al Ameri

0900-0920 Laparoscopic colorectal surgery Speaker: Antonio Privitera

0920-0930 Question & Answer


0945-1005 Surgically Approach in Locally advanced or lo-cally recurrent rectal cancer surgery Speaker: Guido Mann-aerts

1005-1025 Surgical approaches of synchronic liver metasta-sis surgerySpeaker: Salim Al Harthi

1025-1045 Hyperthermic Intraperitoneal Chemotherapy Speaker: Saleh Al Zahrani


Surgery Workshop

www.tawameoc.ae

Day 1

AM




1200-1000ورشة عمل التوعية بالسرطان Cancer Awareness Workshop

Speaker:

Fahad AlkhodairyKing Faisal Specialist Hospital &

Research Center, KSA

Dr Fahad Mohamed AlKHODAIRY, PhD, senior scientist and Chief Medical Research Scientist, Head of Carcinogens Research Unit at King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. Master in Cancer Causes and Mutations in Human Genetics in 1409 (King Saud University) (Faculty of Science, Department of Microbiology) PhD in Cancer Behavior and Effect of Radiation Therapy on Cancer Cells - University of Sussex, Brighton, 1413H. – Britain - Training course in Philadelphia and the National Institute of Health – America Maryland NIH. Author of “Cancer and Genetics” Book.

Presentation & Discussionمحاضرة و نقاش

د.فهد الخضيريكبير علماء ا�بحاث

مركز ا�بحاث بمستشفى الملك فيصل التخصصي

www.tawameoc.ae

Day 1

PM




1300-1400 OPENING CEREMONY

Chair persons: Eman Alshamsi / Maysam Tariq Abu Sa'a

1400-1425 Management of high-dose methotrexate to maximize efficacy and minimize toxicity Speaker: Scott Howard

1425-1450 CAR T for ALL: Efficacy, Safety and Access Speaker: Stephan Grupp

1450-1545 Debate:“Modern Risk Stratified approaches for High Risk T Cell ALL ” Speaker: Scott Howard / Stephan Grupp / Nasser Zain


Chair persons: Anjan Madasu / Samina Afzal

1600-1625 Updates & Advances in the Treatment of Pediatric Sarcomas Speaker: Brian Hansen Ladle

1625-1650 Relapsed / Refractory AML- Saudi Arabian Experience Speaker: Wasil Jastaniah

1650-1730 Debate: “Updates in the management of acute lymphoblastic leukemia across the age spectrum” Asparaginase: pediatric vs. adult regimens) Speaker: Scott Howard / Wasil Jastaniah / Asim Rana


Paediatric Oncology (Hall 1)

www.tawameoc.ae

Day 1

PM





Chair persons: Khalid Abdelgali / Muwaffaq Al GhafoorAbdulrahman Sulaiman Bin Sumaida / Mohamed Said Ahmed

1400-1425 Maxillofacial Implants & Prosthetics for Head & Neck Reconstruction Speaker: Maureen Sullivan

1425-1450 Sentinel Lymph node Biopsy for N0 Oral Cavity Squamous Cancer Speaker: Thom R Loree

1450-1515 Radiation therapy for oropharyngeal cancer Speaker: Helmut Hollenhorst

1515-1545 Medical Management of oropharyngeal cancers Speaker: Hazem El Osta


1600-1630 HPV and Head & Neck Cancer Speaker: Maureen Sullivan

1630-1700 Tumor Board/Case Discussion Two real life cases to be discussed Moderator: D Trad - Abdulghani Elomami (Pathology) - Hussain Ali Aby Ali (Radiology)

1730-1740 Wrap up

Head & Neck

www.tawameoc.ae

Day 2

AM

Friday 8th November 2019




Chair persons: Daniela Jelovac / Mouza Al Ameri Mehboob Mirza / Shaheenah Dawood 0800-0820 Use of breast MRI in breast cancer management Speaker: Dr. Erum Nawaz

0820-0840 Do all patents with DCIS need radiation? Speaker: Dr. Jean-Philippe Pignol

0840-0910 Is chemotherapy needed for all breast cancer patients with 1-3 positive lymph nodes? Speaker: Dr. Cesar Santa-Maria

0910-0930 Management strategies of axilla after neoadjuvant chemotherapy Speaker: Dr. Mehran Habibi


0945-1015 Debate: Do all breast cancer patients with 1-3 positive lymph nodes need post- mastectomy radiation? Speaker: Dr. Jean-Philippe Pignol / Dr. Mehran Habibi

1015-1035 Update on management of ER/PR positive breast cancer Speaker: Dr. Dejan Juric

1035-1055 Update on management of HER2-positive breast caner Speaker: Dr. Mark Pegram

1055-1115 Update on management of Triple Negative Breast Cancer Speaker: Dr. Mark Pegram

1115-1200 Multidisciplinary Tumor board – Case presentation Moderator: Danijela Jelovac

Iram Syed (Pathology) TWMTarek Bin Ashur (Radiology) TWM

Breast (Hall 1)

www.tawameoc.ae

Day 2

AM




0700-0800 REGISTRATION Chair persons: Mona Tareen / Riaz Khan Khyshzai0800-0810 Introduction Speaker: Dr. Zafar Javed 0810-0850 “Role of interventional pain management in neoplasm related pain” Speaker: Dr. Amar Salti0850-0930 “Dr its Hopeless”; having “Hope” in Terminally Ill Patients/families Speaker: Dr. Dulce Cruz-Oliver0930-0945 COFFEE BREAK0945-1020 Psycho-social Issues in Palliative Care… Psycho Oncology Speaker: Dr. Tarek Shahrour1020-1110 Title: Anorexia- Cachexia & other GI symptoms in Cancer Speaker: Dr. Tayyaba Irshad1110-1125 Economic impact of Palliative Care program on Health Care Spending Speaker: Dr. Mohammed Hidayatullah1125-1200 Panel Discussion: Culture Sensitive Care ------ “ AND vs DNR ” End of life Care----------challenges, dilemmas Moderator: Dr. M Zafar Javed Participants: Dr. Cruz-Oliver / Tayyaba Irshad / Salty / Shahrou / Tareen / Dr. Mohammed Hidayatullah

Palliative Care (Hall 2)

www.tawameoc.ae

Day 2

PM





Chair Persons: Abdusalam Alnajjar / Fathi Azribi / Mazen Taha / Norbert Dreier

1430-1500 Treatment of locally advanced/ recurrent rectal Speaker: Dr. Ian Jenkins, Colorectal

1500-1540 Debate 1: ‘watch and wait” vs surgery after neoadjuvant chemo-radiotherapy with complete clinical response 1st Speaker: Prof Ian Jenkins 2nd Speaker: Dr. Saleh Al Zahrani

1540-1555 Discussion


1610-1650 Debate 2: Total neoadjuvant therapy for locally advanced tumors vs long-course chemo radiotherapy alone 1st Speaker: Dr. Robert McWilliams 2nd Speaker: Dr. Humaid Alshamsi

1650-1740 MDT (3 CASES) Moderator: Fathi Azribi - Elnasif Arrayeh - Syed Akhter 1740-1750 Q&A

GI (Hall 1)

www.tawameoc.ae

Day 2

PM




1200-1300 LUNCH BREAK

Chair Persons: Marashi / Mohamed Abu Haleeqa

1430-1500 Adoptive immunotherapy; beyond HSCT Speaker: Dr. Philip McCarthy Jr.

1500-1530 Debate: there is no role of radiotherapy in relapsed Hodgkins lymphoma Speaker: Dr. Hani Osman and Dr. Syed Mansoor Hasnain

1530-1545 Interactive MDT Moderator: Faraz Khan



hair Persons: Asma / Fatima Alkaabi

1610-1640 Management of relapsed MM after auto HSCT and maintenance: Speaker: Dr. Philip McCarthy Jr.

1640-1710 Debate: there is a role of ICE/DHAP in HL in first relapse Speaker: Faraz Khan / Dr. Sabir Hussain

1710-1740 Interactive MDT (CLL and Multiple Myeloma) Moderator: Dr. Amar Lal - Ziad Peerwani - Jorgen Kristensen1740-1750 Question & Answer

ADULT HAEMATOLOGY(Hall 2)

www.tawameoc.ae

Day 2

PM




Plenary Session #2

1330-1430 Chair Persons: Dr Ali ObaidliTopic: Using information systems to make patient care more efficient and improve outcomes Speaker: Dr. Scott Howard

www.tawameoc.ae

Day 3

AM

Saturday 9th November 2019



Chair persons: Dr Khalid Balaraj Stephen Grobmyer

0800-0835 Burnt-Out Among Oncological Professionals Speaker: Dr. Barry Meisenberg

0835-0910 Radiotheranostics for Cancer Speaker: Dr. Martin Pomper

PLENARY SESSION # 3

Radiotheranostics for Cancer

www.tawameoc.ae

Day 3

AM

Saturday9th November 2019



LUNG (HALL 1)


Chair persons: Omran El Koha / James Douglas Emad Dawoud / Gokul Sathyarathnan

0910-0930 How can we overcome TKI resistance in EGFR-Mutant NSCLC ?Speaker: Dr. Hazem El Osta

0930-0950 What’s the role for Immunotherapy with and without chemotherapy in Oncogene Mutated NSCLC? Speaker: Dr. David Planchard

0950-1000 Discussion


1015-1115 Debate: Management of small lung nodule:

Elctromagnetic Navigation Bronchoscopy Speaker: Kelvin Lau VAT Surgery Speaker: Dr. Edward Black SBRT Speaker:Dr. Hollenhirst Helmut

1115-1210 Tumor Board (3 cases of NSCLC) Moderator: Dr Emad Dawoud - Lutfi Ali Kurban (Radiology) TWM - Sulaman Ramadan (Pathology) TWM

www.tawameoc.ae

Day 3

AM





Chair persons: Khalid Al Habaybia (Tawam Hospital) Jijimol Varghese (Al Mafraq)0900-0915 Opening and welcomingSpeaker: Khalid Al Habaybia0915-0935 Introduction in Cancer Care: The New Combination Treatment and The New Side Effects Speaker: Mikaela Olsen0935 -0950 The effectiveness of the navigation program at the breast cancer Centre (BCC) and patient satisfaction at Tawam Hospital Speaker: Khaled Al Qawasmeh0950-1000 Questions and Answers

1000-1015 COFFEE BREAK1015 – 1040 Optimizing infusion center and inpatient bed utilization in the oncology services – Tawam transformational Project Speaker: Mahmoud Hasan1040 -1105 Introduction to the CAR-T Cell Treatment Speaker: Kathy Mooney1105-1130 CChemotherapy Electronic Documentation: Advantages and Benefits Speaker: Mikaela Olsen1130-1140 Questions & Answers1140-1205 Case Studies: The management of Hodgkin Lymphoma with immunotherapy Speaker: Tahani Al Dweikat (SKMC)1205-1210 Closing Remarks Speaker: Jijimol Varghese

Nursing (Hall 2)

www.tawameoc.ae

Day 3

AM




Chair persons: Muhammad Saghir Khan / Amar Lal / Scott Howard0910-0925 Overview of Langerhans cell Histiocytosis among children in Re-source Limited Settings: Single Institutional Experience from Pakistan Speaker: Alia Ahmad0925-0940 Clinical Outcomes of Pediatric Ewing sarcoma and significance of Pathological Necrosis after adjuvant chemotherapy, Single institutional study Speaker: Irfana Ishaq Sindhu0940-0955 IMMUNOPHENOTYPIC PROFILE OF 1148 CASES OF PAEDIATRIC ACUTE LEUKEMIA: A SINGLE CENTER STUDY Speaker: Neelum Mansoor1015-1030 Epidemiology and Surgical Characteristics of Thyroid Cancer in United Arab Emirates: Review of 100 Consecutive Patients Speaker: Reem Al Awadhi1030-1045 Volumetric and dosimetric influence of MR based gross tumour delineation for stereotactic ablative treatment of bone metastases not in-volving spine. Speaker: Arivarasan Ilamurugu1045-1100 Ethics and Quality Education in Radiation Oncology Training pro-gram- a study from tertiary care University Hospital Speaker: Muneeb uddin Karim1100-1115 Image adapted Bladder radiotherapy with “Plan of the day” can avoid Bowel toxicity and allow dose escalation Speaker: Rana Mahmood1115-1130 THE EFFECTIVNESS OF END OF LIFE NURSING EDUCATION PROGRAM ON THE PALLIATIVE CARE KNOWLEDGE AND ATTITUD AND CULTURAL KNOWLEDGE OF MULTINATIONAL CLINICAL NURSES Speaker: Gassan Abudari1130-1145 A RETROSPECTIVE AUDIT TO ASSESS OVERALL DURATION OF TREATMENT TIME IN CARCINOMA OF CERVIX PATIENT TREATED WITH EBRT AND INTRACAVITARY HDR BRACHYTHERAPY Speaker: benazir Mir khan1145-1200 High Notch1 expression is associated with poor prognosis in Adult Patients with Normal karyotype Acute Myeloid Leukemia independent of conventional risk parameters Speaker: GHALEB ELYAMANY

FREE PAPER SESSION

www.tawameoc.ae

Day 3

PM




1210-1300 LUNCH BREAK

Chair persons: Aftab Bhatti / Nouri Bennini Sulaman Magdub / Jawaher Ali Ansari

1300-1320 Sexual function preservation following Radical Prostatectomy: A shared perspective from oncology and Andrology Speaker: Dr. Arthur Burnett

1320-1340 Preservation of continence following radical Prostatectomy- An insight into surgical anatomy of the prostate Speaker: Dr. Mohammed Allaf

1340-1400 Immunotherapy for bladder cancer: is it THE game changer? Speaker: Dr. Jawaher Ansari


1415-1430 High-risk organ confined and locally advanced Prostate cancer: What is the optimum management Speaker: Dr. David Chadwick

1430-1445 Changing paradigms of Metastatic Prostate cancer: Update from the STAMPEDE trial and the implications for current management of hormone sensitive metastatic prostate cancer in the UK Speaker: Dr. Clive Peedel

1445-1500 Radiotherapy for urological cancer: A changing horizon Speaker: Dr. Clive Peedel

1500-1515 CARMENA Trial: What have we learned and the impact on the Kidney cancer management. Speaker: Dr. Mohammad Alaf

1515-1530 Pre Biopsy mpMRI and Prostate biopsy: How best to target the lesion, which route, how many cores? Speaker: Dr. Mohammad Alaf

1530-1630 MDT: To cover Kidney, Prostate, Bladder cancer Moderator: David Chadwick Panel: All of the speakers

GU (HALL 1)Chair persons: Muhammad Saghir Khan / Amar Lal / Scott Howard0910-0925 Overview of Langerhans cell Histiocytosis among children in Re-source Limited Settings: Single Institutional Experience from Pakistan Speaker: Alia Ahmad0925-0940 Clinical Outcomes of Pediatric Ewing sarcoma and significance of Pathological Necrosis after adjuvant chemotherapy, Single institutional study Speaker: Irfana Ishaq Sindhu0940-0955 IMMUNOPHENOTYPIC PROFILE OF 1148 CASES OF PAEDIATRIC ACUTE LEUKEMIA: A SINGLE CENTER STUDY Speaker: Neelum Mansoor1015-1030 Epidemiology and Surgical Characteristics of Thyroid Cancer in United Arab Emirates: Review of 100 Consecutive Patients Speaker: Reem Al Awadhi1030-1045 Volumetric and dosimetric influence of MR based gross tumour delineation for stereotactic ablative treatment of bone metastases not in-volving spine. Speaker: Arivarasan Ilamurugu1045-1100 Ethics and Quality Education in Radiation Oncology Training pro-gram- a study from tertiary care University Hospital Speaker: Muneeb uddin Karim1100-1115 Image adapted Bladder radiotherapy with “Plan of the day” can avoid Bowel toxicity and allow dose escalation Speaker: Rana Mahmood1115-1130 THE EFFECTIVNESS OF END OF LIFE NURSING EDUCATION PROGRAM ON THE PALLIATIVE CARE KNOWLEDGE AND ATTITUD AND CULTURAL KNOWLEDGE OF MULTINATIONAL CLINICAL NURSES Speaker: Gassan Abudari1130-1145 A RETROSPECTIVE AUDIT TO ASSESS OVERALL DURATION OF TREATMENT TIME IN CARCINOMA OF CERVIX PATIENT TREATED WITH EBRT AND INTRACAVITARY HDR BRACHYTHERAPY Speaker: benazir Mir khan1145-1200 High Notch1 expression is associated with poor prognosis in Adult Patients with Normal karyotype Acute Myeloid Leukemia independent of conventional risk parameters Speaker: GHALEB ELYAMANY

www.tawameoc.ae

Day 3

PM




1200-1300 LUNCH BREAKChair persons: Elpidoforos Soteriades / Shima Babiker Ismail 1300-1340 Safe Handling of Cytotoxic Drugs and Agents in the Workplace: Associated European Guidelines Speaker: Stavroula Theophanous-Kitiri1340-1420 Cytotoxic Drugs: Environmental Risk Assessment in the Hospital Setting Speaker: Dr. Jerald Ovesen1420-1430 COFFEE BREAK1430-1510 Health Risks Associated with Exposure to Hazardous Drugs: Current Challenges Speaker: Elpidoforos S. Soteriades1510-1530 National Policies and Hospital Guidelines on Cytotoxic Drugs across the United Arab Emirates (UAE) Speaker: Dr Maria Aamir1530-1600 Panel Discussion: Policies, Guidelines, Practices, and Research on Cytotoxic Drugs in UAEModerator: Dr Elpidoforos S. SoteriadesPanel Discussion: All Speakers

OCCUPATIONAL HEALTHWORKSHOP (HALL 2)

8eoc agenda 2019 - downloadable 003€¦ · king faisal specialist hospital & research center,...

Documents